United Therapeutics Corporation (UTHR)

Business: United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

IPO Date: 17-Jun-1999

Founder, Chairman & CEO: Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.

Pres & COO: Mr. Michael I. Benkowitz

Listing: NASDAQ: UTHR

Country: United States

Headquarters: Silver Spring, MD

Website: https://www.unither.com

Market cap: $10,824.31 Mln

Revenue (TTM): $1,768.30 Mln

Earnings (TTM): $687.40 Mln

Cash: $2,267.70 Mln

Total Debt: $800.00 Mln

Insider's Holding: 1.77%

Liquidity: Low

52 Week range: $158.38 - 243.16

Shares outstanding: 45,299,500

10 Years Aggregate:

• CFO: $4,529.72 Mln
• EBITDA: $6,233.69 Mln
• Net Profit: $4,076.82 Mln